Last week not only did shares in Dexcom get hammered after their earnings announcement the company is also taking a virtual beating on social media over their decision to transfer customer support functions to lower cost areas. While no one is favor of shipping jobs overseas this was a very necessary decision that had to be made. For these same people who are bitching about poor customer service also complain about the high cost of the products they use.
Frankly every diabetes device company is caught in this catch-22 situation how to provide low cost products which carry with . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.